Compass Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Compass Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q3 2024.
  • Compass Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $6.95M, a 234% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $6.95M +$4.87M +234% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $1.15M -$1.23M -51.7% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $1.47M -$1.21M -45.3% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $1.78M -$1.19M -40.1% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $2.08M -$1.17M -36% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $2.39M -$1.16M -32.6% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $2.68M -$1.14M -29.8% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $2.97M -$1.12M -27.4% Dec 31, 2022 10-K 2024-03-21
Q3 2022 $3.26M -$1.11M -25.4% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $3.54M -$1.09M -23.5% Jun 30, 2022 10-Q 2022-08-01
Q1 2022 $3.82M -$1.07M -21.9% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $4.09M +$4.09M Dec 31, 2021 10-K 2023-03-15
Q3 2021 $4.36M Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $4.63M Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $4.89M Mar 31, 2021 10-Q 2021-04-30
Q4 2020 $0 Dec 31, 2020 10-K 2022-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.